ZipRecruiter

Log In

1

Contract Biotech Investor Relations Jobs (NOW HIRING)

United Therapeutics Corporation

$90 - $130/hr

Who We AreWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients ...

Travere

Analyst, Investor Relations

San Diego, CA · On-site

Department: 101200 Investor Relations Location: San Diego Be a part of a global team that is ... Strong interest in capital markets, investing, biotechnology, healthcare, and current events ...

next page

Showing results 1-20

All Jobsfreelance JobsFinance and Insurance JobsFinancial Services JobsInvestor Relations Associate JobsContract Biotech Investor Relations Jobs

Contract Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do contract biotech investor relations jobs pay per year?

As of Sep 7, 2026, the average yearly pay for contract biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What is a contract biotech investor relations professional?

Contract Biotech Investor Relations professionals are specialists hired on a temporary or project basis to manage communications between biotechnology companies and their investors. They help ensure that all investor communications, financial disclosures, and company updates are clear, compliant, and strategically aligned with the company's goals. These professionals often support fundraising efforts, prepare investor materials, coordinate meetings, and handle inquiries from current or potential investors. Their expertise helps biotech companies build and maintain strong relationships with the investment community, especially during pivotal events such as clinical trial announcements or capital raises.

What are the key skills and qualifications needed to thrive as a contract biotech investor relations professional?

To thrive as a Contract Biotech Investor Relations professional, you need a solid background in finance, biotechnology, and communications, often supported by a relevant degree and industry experience. Familiarity with financial modeling tools, investor databases, CRM systems, and compliance platforms is typically required. Exceptional interpersonal skills, strategic thinking, and the ability to distill complex scientific concepts for diverse stakeholders are crucial soft skills in this role. These competencies are essential for building investor trust, ensuring regulatory compliance, and effectively communicating a company's value proposition to the financial community.

What are the main challenges faced by a contract biotech investor relations professional when communicating complex scientific information to investors?

A Contract Biotech Investor Relations professional often faces the challenge of translating intricate scientific data and clinical trial results into clear, compelling messages that investors can understand. Balancing technical accuracy with investor accessibility is crucial, as miscommunication can impact investor confidence and company reputation. Additionally, keeping up with rapidly evolving scientific developments and regulatory updates, while responding promptly to investor inquiries, requires strong communication and project management skills.

What is the difference between Contract Biotech Investor Relations vs Contract Biotech Communications?

AspectContract Biotech Investor RelationsContract Biotech Communications
Primary FocusManaging investor relations, financial communication, and shareholder engagementDeveloping public relations, media outreach, and brand messaging
Required SkillsFinancial analysis, investor communication, regulatory complianceMedia relations, content creation, branding strategies
Work EnvironmentCorporate offices, investor meetings, financial eventsMedia outlets, marketing agencies, corporate communications teams

Contract Biotech Investor Relations primarily focuses on managing relationships with investors and communicating financial information, while Contract Biotech Communications emphasizes public relations and brand messaging. Both roles require strong communication skills but serve different strategic purposes within biotech companies.

What cities are hiring for Contract Biotech Investor Relations jobs?

Cities with the most Contract Biotech Investor Relations job openings:

What are the most commonly searched types of Biotech Investor Relations jobs?

The most popular types of Biotech Investor Relations jobs are:

What states have the most Contract Biotech Investor Relations jobs?

States with the most job openings for Contract Biotech Investor Relations jobs include:

Contract Biotech Investor Relations jobs near you
Infographic showing various Contract Biotech Investor Relations job openings in the United States as of July 2026, with employment types broken down into 1% Locum Tenens, 2% As Needed, 89% Full Time, 1% Part Time, 1% Temporary, and 6% Contract. Highlights an 82% Physical, 3% Hybrid, and 15% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Director or Senior Director, Investor Relations and Communications

Scorpion Therapeutics

California, MD • On-site

$220 - $300/hr

Other

Posted 8 days ago

Job description

POSITION SUMMARY:

  • Formulate an integrated vision and strategy for communicating effectively with the investor community to drive positive brand recognition and strong investor interest.


KEY ROLE AND RESPONSIBILITIES:

  • Collaborate with C-suite and product teams to develop and execute investor communications strategy (quarterly filings, conference calls, investor conferences, roadshows).

  • Lead a comprehensive strategic/tactical communications plan for investor relations objectives.

  • Ensure effective, consistent corporate communications and keep strategy/progress top of mind.

  • Partner with Finance and Legal to ensure investor-facing communications are robust, timely, accurate, and compelling.

  • Develop key messages, FAQs, and talking points for investor/analyst events.

  • Train and advise spokespeople for media/press and industry presentations; prepare briefing materials.

  • Build relationships with analysts, investors, media, influencers, and partners; serve as an on-record spokesperson.

  • Partner with media/PR agency/external partners to develop and execute campaigns; monitor brand activity.

  • Manage proactive and responsive communications, including crisis communications and rapid response.

  • Track competitor and peer company announcements.


PREFERRED EDUCATION:

  • Bachelor’s degree in a scientific discipline (Communications/Marketing or related with significant biotech experience). Master’s degree a plus.


PREFERRED EXPERIENCE:

  • Senior Director: 10+ years PR (prefer investor relations), corporate communications, or media; 8+ years management/leadership.

  • Director: 7–9 years PR (prefer investor relations), corporate communications, or media; 5–7 years management/leadership.

  • Biotech investor relations/corporate communications or sell-side analyst experience; track record supporting financing, conferences, and product launches.


KNOWLEDGE, SKILLS AND ABILITIES:

  • Cross-functional leadership through complexity; influence multiple stakeholders.

  • Executive presence; strategic thinking with detail focus.

  • Prioritize and execute competing priorities in a fast-moving environment.

  • Strong written/verbal communication; tailor messages to diverse audiences; agile, sound judgment.

  • Willingness to “roll-up your sleeves” from strategy to execution.


COMPENSATION/OTHER:

  • Salary range: $220,000–$300,000 annually; annual bonus opportunity.

  • Eligible for Lyell’s Equity Incentive Plan.

#J-18808-Ljbffr

Apply